Aspire Biopharma Holdings Inc. logo

Aspire Biopharma Holdings Inc. (ASBP)

Market Closed
15 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS)
$
8. 64
+0.48
+5.8824%
Pre Market
$
8. 98
+0.34 +3.9352%
957.59K Market Cap
- P/E Ratio
- Div Yield
31,856 Volume
- Eps
$ 8.16
Previous Close
Add Transaction
Day Range
7.98 8.78
Year Range
0.11 562.8
Want to track ASBP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Aspire Biopharma Holdings Inc. (ASBP) Statistics

Valuation metrics

Market Cap 957.59K
Enterprise value -11.21M
Trailing P/E (ttm) -1.03
Forward P/E -
PEG ratio -0.01
Price/Sales (ttm) 9.81
Price/Book (mrq) 0.73
Enterprise Value/Revenue -114.78
Enterprise Value/EBITDA -3.41

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 22.65K
Average volume (90 days) 31.56K

Price summary

52-Week low 0.11
52-Week high 562.8
Beta -
50-Day moving average 8.59
200-Day moving average 13.55

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:30
Last split Date 11 May 2026

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -113.14%
Operating margin -72.6%

Operational effectiveness

Return on assets -0.82%
Return on equity 19.93%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 0.09
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -10.65
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 11.72
Total debt (mrq) -
Total Debt/Equity (mrq) 0.39
Current ratio (mrq) 7.99%
Book value per share (mrq) 11.33

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -